JPIAMR
Antimicrobial Resistance - The Microbial Challenge - An Emerging Threat to Human Health
Antibiotic resistance is a global problem for all of us. Resistance leads to infections that cannot be easily treated with the current antibiotics. A global reduction of the resistance of harmful microbes to treatment such as antibiotics will lead to reduced health costs and saved lives. Research of the resistance in Europe is fragmented and few countries have specific programs dedicated to this field of research. To reach this goal, 23 countries have joined forces in the Joint Programme Initiative on Antimicrobial Resistance (JPIAMR) to coordinate the research, in order to allow greater impact and avoid duplication. Only by bringing together industry, public health bodies and academic bodies to share experience and resources across scientific disciplines will we be able to create long term reduction of antimicrobial resistance in Europe.
Important documents
- JPIAMR Strategic Research and Innovation Agenda (2019)
- JPIAMR Strategic Research and Innovation Agenda (2013)
- JPIAMR Roadmap of Actions 2019-2024
- JPIAMR Future Strategy 2020-2025
Joint Actions
JPIAMR organises workshops to identify future joint actions. By bringing together experts from all relevant fields relating to a specific topic, the workshops can map the landscape and identify knowledge gaps. The added value of JPIAMR is that through its funding mechanisms and collaborative actions, the initiative can set in motion activities to fill these knowledge gaps.
Calls
2020: JPIAMR Network Plus 2020
2020: Knowledge transfer of research on AquaticPollutants, together with JPI Water and JPI Oceans
2020: AquaticPollutants, together with JPI Water and JPI Oceans
2019: JPIAMR Joint Call on Diagostics and Surveillance 2019
2018: JPIAMR-VRI Network Call 2018
2018: JPIAMR Network Call on Surveillance 2018
2018: Innovations against antibiotic-resistant bacteria: new targets, compounds and tools, within the ERA-NET JPI-EC-AMR
2017: Prevention and Intervention Strategies to control AMR infections
Interviews related to JPIAMR
Repotentiating Beat lactam antibiotics (REBEL), interview with RIKILT microbiologist researcher Mariƫl Pikkemaat